Douglas S Krakower
Overview
Explore the profile of Douglas S Krakower including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gravett R, Long D, Biello K, Mayer K, Krakower D, Hill-Rorie J, et al.
J Acquir Immune Defic Syndr
. 2025 Feb;
PMID: 39976527
Introduction: Pre-exposure prophylaxis (PrEP) cannot meaningfully impact the HIV epidemic in the United States without improving access to PrEP and reducing PrEP disparities among gay, bisexual, and other men who...
2.
Traeger M, Leyden W, Volk J, Silverberg M, Horberg M, Davis T, et al.
JAMA Intern Med
. 2025 Jan;
185(3):273-281.
PMID: 39761062
Importance: Doxycycline postexposure prophylaxis (doxyPEP) has been shown to decrease the incidence of bacterial sexually transmitted infections (STIs) among people assigned male sex at birth in clinical trials, but data...
3.
Traeger M, Krakower D, Mayer K, Jenness S, Marcus J
Sex Transm Dis
. 2024 Aug;
51(12):763-771.
PMID: 39115204
Background: Doxycycline used as postexposure prophylaxis (doxyPEP) within 72 hours of sex reduces the risk of bacterial sexually transmitted infections (STIs) in people assigned male sex at birth. Little is...
4.
Volk J, Leyden W, Lea A, Lee C, Donnelly M, Krakower D, et al.
J Acquir Immune Defic Syndr
. 2024 Feb;
95(4):362-369.
PMID: 38412047
Background: Preexposure prophylaxis (PrEP) use remains limited and inequitable, and strategies are needed to improve PrEP provision in primary care. Methods: We conducted a cluster randomized trial at Kaiser Permanente,...
5.
Psaros C, Hill-Rorie J, Quint M, Horvitz C, Dormitzer J, Biello K, et al.
AIDS Care
. 2023 Sep;
36(6):732-743.
PMID: 37748111
New HIV infections disproportionately affect young men who have sex with men (YMSM). PrEP is effective in preventing HIV acquisition; however, adherence is critical and is often suboptimal among YMSM....
6.
Traeger M, Mayer K, Krakower D, Gitin S, Jenness S, Marcus J
Clin Infect Dis
. 2023 Aug;
PMID: 37595139
Background: Doxycycline post-exposure prophylaxis (doxyPEP) reduces bacterial sexually transmitted infection (STI) incidence in people with HIV (PWH) or using HIV preexposure prophylaxis (PrEP). Given concerns about widespread antibiotic use, we...
7.
Traeger M, Krakower D, Mayer K, Marcus J
Lancet HIV
. 2023 Aug;
10(10):e690-e692.
PMID: 37573870
Benefits of pre-exposure prophylaxis (PrEP) extend beyond HIV risk reduction. Users report a range of physical, emotional, and social effects, including reduced anxiety, increased intimacy, and greater sexual satisfaction. For...
8.
Rawlins-Pilgrim S, Wheelock A, Streed Jr C, Higham M, Krakower D, Taylor J
J Am Coll Health
. 2023 Jul;
73(2):458-461.
PMID: 37463515
To determine HIV pre-exposure prophylaxis (PrEP) availability at student health services (SHS) in New England. We conducted an electronic survey of medical directors of SHS at New England colleges and...
9.
Calabrese S, Krakower D, Rao S, Hansen N, Mayer K, Magnus M, et al.
AIDS Behav
. 2023 Jul;
27(12):3932-3940.
PMID: 37401992
Enhanced provider training could improve PrEP access and equity. We conducted a pilot randomized controlled trial comparing (a) a one-hour, group-based provider intervention integrating PrEP and Cultural Competence (PCC) training...
10.
Sewak A, Lodi S, Li X, Shu D, Wen L, Mayer K, et al.
Am J Epidemiol
. 2023 Apr;
193(1):6-16.
PMID: 37073419
Antiretroviral preexposure prophylaxis (PrEP) is highly effective in preventing human immunodeficiency virus (HIV) infection, but uptake has been limited and inequitable. Although interventions to increase PrEP uptake are being evaluated...